Systemic Inflammation Response Index (SIRI) Predicts Clinical Outcome and Improves NCCN-IPI Scoring in Primary Gastrointestinal Diffuse Large B-Cell Lymphoma
- Resource Type
- Article
- Authors
- Chu, Yurou; Zhou, Xiangxiang; Liu, Yingyue; Zhan, Linquan; Fang, Xiaosheng; Li, Ying; Wang, Xin
- Source
- Blood; November 2021, Vol. 138 Issue: 1, Number 1 Supplement 1 p1432-1432, 1p
- Subject
- Language
- ISSN
- 00064971; 15280020
Background:Systemic inflammation response index (SIRI) is a novel inflammatory hallmark that is proposed as an adverse prognosticator in a variety of malignancies. Nevertheless, the correlation between SIRI and primary gastrointestinal diffuse large B cell lymphoma (PGI-DLBCL) remains unknown. Our study aimed to evaluate the prognostic value of SIRI in PGI-DLBCL patients treated with CHOP-based therapies and establishing a highly discriminating risk prediction model compared with the National Comprehensive Cancer Network-International Prognostic Index (NCCN-IPI) score.